What Is the First-Line Treatment for Primary Dysmenorrhea?
Primary dysmenorrhea is recurrent menstrual pain that occurs in the absence of identifiable pelvic pathology. Management is directed at a single, clearly defined goal: relief of menstrual pain.
Treatment approach
A specific class of anti-inflammatory medication — supported by strong evidence from a large body of randomised controlled trials — forms the cornerstone of first-line care, with hormonal and non-pharmacological options available as part of the broader management strategy.
The complete protocol — covering which agents to use, the timing strategy, the full range of alternatives, and guidance on when to escalate — is available below.
Treatment goal
Relief of menstrual (dysmenorrhea) pain.
References
- A Cochrane review of 73 randomized controlled trials (RCTs) demonstrated strong evidence to support nonsteroidal anti-inflammatory drugs (NSAIDs) as the first-line treatment for primary dysmenorrhea.
- Oral, intravaginal, and intrauterine hormonal contraceptives have been recommended for management of primary dysmenorrhea; however, the evidence supporting their effectiveness is limited.
- Exercise and nutritional interventions (supplementation or increased intake of omega-3 fatty acids and vitamin B) may provide some benefit, but the evidence is limited to small RCTs.
View source ↗